Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues Calix Inc CALX Q1 2026 Earnings EPS Matches Estimates as Broadband Demand Holds Steady HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline TDS Q1 2026 Earnings Massive EPS Beat Despite Stock Decline IHG Q4 2025 Earnings EPS Slightly Misses Estimates as Stock Edges Lower